Fraietta et al. revealed that the extent of sustained remission within responding CLL patients to CD19 CAR-T cells, correlated with increased frequency of memory markers CD27+CD45RO−CD8+ T cells prior to CAR-T cell generation [137]. Here, CD19 is linked to B-cell chronic lymphocytic leukemia.